bearish
Korea Shorts Data Analysis (#1): Celltrion, Samsung Biologics, DS Infracore, HLB, & Hotel Shilla
384 Views01 Nov 2019 22:11
This is our first inaugural edition of the Korea Shorts Data Analysis. We plan to make this into a regular piece. We broke down the Korean shorts...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
- Korea Shorts Data Analysis (#3): LG H&H, Amorepacific, KMW, Hotel Shilla, & DSINFRA02 Dec 2019
- One Simple Rule to Beat the Market in Korea - SAMSUNG02 Dec 2019
- Korea Shorts Data Analysis (#2): HLB, Fila Korea, DS Infracore, Helixmith, Korea Kolmar, & Cosmax18 Nov 2019
- SK Holdings Buyback Progress & IPO of SK Biopharm - The Next Big Catalyst25 Oct 2019
- KMW - A Shorting Opportunity15 Oct 2019
- Huuuge Share Buyback for SK Holdings01 Oct 2019
x